Synthesis and mechanism-of-action of a novel synthetic antibiotic based on a dendritic system with bow-tie topology
暂无分享,去创建一个
T. Mascher | A. Revilla-Guarinos | P. Popp | R. Gómez | F. J. de la Mata | T. Lozano-Cruz | F. Dürr | Johanna Hartig | Ainhoa Revilla-Guarinos
[1] T. Mascher,et al. Silver (I) N-Heterocyclic Carbenes Carbosilane Dendritic Systems and Their Imidazolium-Terminated Analogues as Antibacterial Agents: Study of Their Mode of Action , 2020, Pharmaceutics.
[2] T. Mascher,et al. Amphotericin B Specifically Induces the Two-Component System LnrJK: Development of a Novel Whole-Cell Biosensor for the Detection of Amphotericin-Like Polyenes , 2020, Frontiers in Microbiology.
[3] P. Gabant,et al. In the Age of Synthetic Biology, Will Antimicrobial Peptides be the Next Generation of Antibiotics? , 2020, Antibiotics.
[4] F. González-Nilo,et al. CATIONIC CARBOSILANE DENDRITC SYSTEMS AS PROMISING ANTI-AMYLOID AGENTS IN TYPE 2 DIABETES. , 2020, Chemistry.
[5] T. Mascher,et al. The Epipeptide YydF Intrinsically Triggers the Cell Envelope Stress Response of Bacillus subtilis and Causes Severe Membrane Perturbations , 2020, Frontiers in Microbiology.
[6] T. Lu,et al. Peptide Design Principles for Antimicrobial Applications. , 2019, Journal of molecular biology.
[7] F. Albericio,et al. Carbosilane Dendron-Peptide Nanoconjugates as Antimicrobial Agents. , 2019, Molecular pharmaceutics.
[8] D. Britti,et al. Antileishmanial Activity of Amphotericin B-loaded-PLGA Nanoparticles: An Overview , 2018, Materials.
[9] M. Malý,et al. Ammonium and guanidine carbosilane dendrimers and dendrons as microbicides , 2018 .
[10] J. Errington,et al. Lysozyme Counteracts β-Lactam Antibiotics by Promoting the Emergence of L-Form Bacteria , 2018, Cell.
[11] J. Errington,et al. Mode of Action and Heterologous Expression of the Natural Product Antibiotic Vancoresmycin. , 2017, ACS chemical biology.
[12] Jörg Stülke,et al. SubtiWiki in 2018: from genes and proteins to functional network annotation of the model organism Bacillus subtilis , 2017, Nucleic Acids Res..
[13] T. Mascher,et al. The Bacillus BioBrick Box 2.0: expanding the genetic toolbox for the standardized work with Bacillus subtilis , 2017, Scientific Reports.
[14] T. G. Villa,et al. Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteria. , 2017, Biochemical pharmacology.
[15] T. Mascher,et al. Membrane chaperoning by members of the PspA/IM30 protein family , 2017, Communicative & Integrative Biology.
[16] H. Sahl,et al. Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains , 2016, Proceedings of the National Academy of Sciences.
[17] Ellen M. Quardokus,et al. MicrobeJ, a tool for high throughput bacterial cell detection and quantitative analysis , 2016, Nature Microbiology.
[18] Georg Fritz,et al. Anatomy of the bacitracin resistance network in Bacillus subtilis , 2016, Molecular microbiology.
[19] L. Hamoen,et al. Analysis of Antimicrobial-Triggered Membrane Depolarization Using Voltage Sensitive Dyes , 2016, Front. Cell Dev. Biol..
[20] R. Gómez,et al. Structure–activity relationship study of cationic carbosilane dendritic systems as antibacterial agents , 2016 .
[21] T. Mascher,et al. Cannibalism stress response in Bacillus subtilis. , 2016, Microbiology.
[22] Marc Mendelson,et al. The World Health Organization Global Action Plan for antimicrobial resistance. , 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[23] R. P. Ross,et al. Lantibiotic Resistance , 2015, Microbiology and Molecular Reviews.
[24] R. Gómez,et al. Evaluation of the activity of new cationic carbosilane dendrimers on trophozoites and cysts of Acanthamoeba polyphaga , 2015, Parasitology Research.
[25] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[26] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[27] Georg Fritz,et al. The Bacillus BioBrick Box: generation and evaluation of essential genetic building blocks for standardized work with Bacillus subtilis , 2013, Journal of Biological Engineering.
[28] M. Bramkamp,et al. Flotillins functionally organize the bacterial membrane , 2013, Molecular microbiology.
[29] R. Hamill. Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity , 2013, Drugs.
[30] M. Preobrazhenskaya,et al. Structure-Antifungal Activity Relationships of Polyene Antibiotics of the Amphotericin B Group , 2013, Antimicrobial Agents and Chemotherapy.
[31] T. Mascher,et al. Cell Envelope Stress Response in Cell Wall-Deficient L-Forms of Bacillus subtilis , 2012, Antimicrobial Agents and Chemotherapy.
[32] H. Sahl,et al. Proteomic Response of Bacillus subtilis to Lantibiotics Reflects Differences in Interaction with the Cytoplasmic Membrane , 2012, Antimicrobial Agents and Chemotherapy.
[33] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[34] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[35] B. Schwikowski,et al. Condition-Dependent Transcriptome Reveals High-Level Regulatory Architecture in Bacillus subtilis , 2012, Science.
[36] J. Helmann,et al. Analysis of the role of Bacillus subtilis σM in β‐lactam resistance reveals an essential role for c‐di‐AMP in peptidoglycan homeostasis , 2012, Molecular microbiology.
[37] Gisbert Schneider,et al. Designing antimicrobial peptides: form follows function , 2012, Nature Reviews Drug Discovery.
[38] T. Mascher,et al. Antibiotic research in the age of omics: from expression profiles to interspecies communication. , 2011, The Journal of antimicrobial chemotherapy.
[39] Thorsten Mascher,et al. Peptide Antibiotic Sensing and Detoxification Modules of Bacillus subtilis , 2010, Antimicrobial Agents and Chemotherapy.
[40] Janine Kirstein,et al. In-Depth Profiling of the LiaR Response of Bacillus subtilis , 2010, Journal of bacteriology.
[41] R. H. Baltz. Renaissance in antibacterial discovery from actinomycetes. , 2008, Current opinion in pharmacology.
[42] N. Brunner,et al. How many modes of action should an antibiotic have? , 2008, Current opinion in pharmacology.
[43] D. Rai,et al. Engineered synthesis of 7-oxo- and 15-deoxy-15-oxo-amphotericins: insights into structure-activity relationships in polyene antibiotics. , 2008, Chemistry and Biology.
[44] Amitabha Chattopadhyay,et al. The gramicidin ion channel: a model membrane protein. , 2007, Biochimica et biophysica acta.
[45] Christoph Freiberg,et al. Novel Whole-Cell Antibiotic Biosensors for Compound Discovery , 2007, Applied and Environmental Microbiology.
[46] Thorsten Mascher,et al. Regulation of LiaRS-Dependent Gene Expression in Bacillus subtilis: Identification of Inhibitor Proteins, Regulator Binding Sites, and Target Genes of a Conserved Cell Envelope Stress-Sensing Two-Component System , 2006, Journal of bacteriology.
[47] M. Sarvas,et al. Cationic antimicrobial peptides elicit a complex stress response in Bacillus subtilis that involves ECF-type sigma factors and two-component signal transduction systems. , 2005, Microbiology.
[48] Sara L. Zimmer,et al. Antibiotic-Inducible Promoter Regulated by the Cell Envelope Stress-Sensing Two-Component System LiaRS of Bacillus subtilis , 2004, Antimicrobial Agents and Chemotherapy.
[49] Christoph Schaab,et al. Panel of Bacillus subtilis Reporter Strains Indicative of Various Modes of Action , 2004, Antimicrobial Agents and Chemotherapy.
[50] R. Benz,et al. Lipid II-Mediated Pore Formation by the Peptide Antibiotic Nisin: a Black Lipid Membrane Study , 2004, Journal of bacteriology.
[51] Tao Wang,et al. Cell wall stress responses in Bacillus subtilis: the regulatory network of the bacitracin stimulon , 2003, Molecular microbiology.
[52] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[53] Oscar P. Kuipers,et al. Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity* , 2001, The Journal of Biological Chemistry.
[54] O. Kuipers,et al. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. , 1999, Science.
[55] Doris Ma Fat,et al. WHO Library Cataloguing-in-Publication Data , 2001 .
[56] D. Cheo,et al. Cloning and characterization of DNA damage-inducible promoter regions from Bacillus subtilis , 1991, Journal of bacteriology.
[57] C. Anagnostopoulos,et al. REQUIREMENTS FOR TRANSFORMATION IN BACILLUS SUBTILIS , 1961, Journal of bacteriology.